- First efficacy data on bivalent boosters shows they work against infection https://arstechnica.com/science/2022/11/bivalent-shots-boost-protection-against-symptomatic-covid-cdc-study-finds/ 42 comments health
Linking pages
- Report: Spring COVID booster to be authorized for high-risk people in US | Ars Technica https://arstechnica.com/science/2023/04/report-spring-covid-booster-to-be-authorized-for-high-risk-people-in-us/ 1 comment
- Android TV will require App Bundles in 2023, should reduce app size by 20% | Ars Technica https://arstechnica.com/gadgets/2022/11/android-tv-will-require-app-bundles-in-2023-should-reduce-app-size-by-20/ 0 comments
Linked pages
- CDC COVID Data Tracker https://covid.cdc.gov/covid-data-tracker/#trends_dailycases 531 comments
- Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection â Increasing Community Access to Testing Program, United States, SeptemberâNovember 2022 | MMWR https://www.cdc.gov/mmwr/volumes/71/wr/mm7148e1.htm 0 comments
- Android TV will require App Bundles in 2023, should reduce app size by 20% | Ars Technica https://arstechnica.com/gadgets/2022/11/android-tv-will-require-app-bundles-in-2023-should-reduce-app-size-by-20/ 0 comments
Related searches:
Search whole site: site:arstechnica.com
Search title: First efficacy data on bivalent boosters shows they work against infection | Ars Technica
See how to search.